Market Value461,482,322
Total Holdings54
File Date2023-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
NGM / NGM Biopharmaceuticals, Inc.
GRPH / Graphite Bio, Inc.
NVAX / Novavax, Inc.
NVAX / Novavax, Inc. Call
RYTM / Rhythm Pharmaceuticals, Inc.
STRO / Sutro Biopharma, Inc.
SYRS / Syros Pharmaceuticals, Inc.
EQ / Equillium, Inc.
SRRK / Scholar Rock Holding Corporation
ISEE / IVERIC bio Inc
HLVX / HilleVax, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
NKTX / Nkarta, Inc.
DBTX / Decibel Therapeutics Inc
KRON / Kronos Bio, Inc.
US03217L1061 / Amryt Pharma PLC Sponsored ADR (United Kingdom)
ATXS / Astria Therapeutics, Inc.
SWTX / SpringWorks Therapeutics, Inc.
SRZN / Surrozen, Inc.
BLSA / BCLS Acquisition Corp - Class A
RAIN / Rain Enhancement Technologies Holdco, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
JYAC / Jiya Acquisition Corp - Class A
AVDL / Avadel Pharmaceuticals plc
JANX / Janux Therapeutics, Inc.
ALVR / AlloVir, Inc.
IOBT / IO Biotech, Inc.
FMTX / Forma Therapeutics Holdings Inc
SRZNW / Surrozen, Inc. - Equity Warrant
AGLE / Aeglea BioTherapeutics Inc
ALBO / Albireo Pharma Inc
PEPG / PepGen Inc.
ICPT / Intercept Pharmaceuticals Inc
PRME / Prime Medicine, Inc.
KDNY / Chinook Therapeutics Inc
LSAQ / LifeSci Acquisition II Corp
ZYME / Zymeworks Inc.
ELEV / Elevation Oncology, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
ALXO / ALX Oncology Holdings Inc.
BCEL / Atreca, Inc.
KALA / KALA BIO, Inc.
TIL / Instil Bio, Inc.
IMTX / Immatics N.V.
DICE / DICE Therapeutics Inc
EYPT / EyePoint Pharmaceuticals, Inc.
LYRA / Lyra Therapeutics, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
VTVT / vTv Therapeutics Inc.
BOLT / Bolt Biotherapeutics, Inc.
IGMS / IGM Biosciences, Inc.
VIRX / Viracta Therapeutics, Inc.
ACRS / Aclaris Therapeutics, Inc.
TERN / Terns Pharmaceuticals, Inc.
TNGX / Tango Therapeutics, Inc.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
ACLX / Arcellx, Inc.
ALLK / Allakos Inc.